United States Surgical Dressings Market Size, Share, Growth, Trends, and Forecast 2026–2034

United States Surgical Dressings Market Overview

The United States surgical dressings market is projected to grow from US$1.47 billion in 2025 to US$2.09 billion by 2034, registering a compound annual growth rate (CAGR) of 3.98% during 2026–2034. Market expansion is driven by the rising number of surgical procedures, increasing prevalence of chronic wounds, an aging population, and growing adoption of advanced wound-care technologies.

Surgical dressings are essential medical products used to protect surgical incisions, absorb wound fluids, maintain appropriate moisture levels, and support the healing process. The market includes conventional gauze and adhesive dressings alongside advanced solutions such as antimicrobial dressings, hydrocolloids, foam dressings, alginates, hydrogels, transparent films, and bioactive materials.

The United States has an extensive healthcare infrastructure comprising hospitals, ambulatory surgery centers, specialty clinics, long-term care facilities, and home healthcare providers. These facilities require surgical dressings for postoperative care, trauma management, burns, ulcers, and complex chronic wounds.

Additionally, technological advancements are encouraging healthcare providers to adopt products offering improved absorbency, skin protection, antimicrobial performance, and longer wear times. As healthcare organizations increasingly prioritize infection prevention, patient comfort, and cost-efficient treatment, demand for specialized surgical dressings is expected to increase throughout the forecast period.

Explore the full report: United States Surgical Dressings Market — Renub Research.

What Are Surgical Dressings and Why Are They Important?

Surgical dressings are medical materials applied to wounds, surgical incisions, and damaged skin to provide physical protection and support healing. Depending on their design, they can absorb excess wound fluid, maintain a suitable moisture balance, reduce exposure to contaminants, and protect surrounding skin.

Common types of surgical dressings include:

• Gauze dressings: Conventional products used for wound coverage and fluid absorption.
• Foam dressings: Designed to manage moderate to heavy wound exudate.
• Hydrocolloid dressings: Help maintain a moist environment for selected wounds.
• Alginate dressings: Used for wounds requiring substantial fluid absorption.
• Hydrogel dressings: Provide moisture to selected wounds.
• Transparent film dressings: Allow visual inspection of the covered area.
• Antimicrobial dressings: Incorporate antimicrobial materials, such as silver, for specific wound-management applications.
• Bioactive dressings: Use specialized materials designed to support particular aspects of wound management.

These products are used in postoperative incision management, cardiovascular procedures, orthopedic surgery, diabetic wound care, burns, ulcers, and skin-graft donor sites.

Demand is supported by the size of the U.S. patient population and the growing need for effective wound management. The population aged 65 and older reached approximately 64.6 million in 2025, accounting for nearly 18.9% of the national population. Older adults are more likely to experience chronic diseases, fragile skin, and delayed wound healing, increasing the need for appropriate wound-care products.

Key Growth Drivers of the United States Surgical Dressings Market

1. Rising Surgical Procedures and Postoperative Care Requirements

The continued volume of surgical procedures across the United States represents a major source of demand for surgical dressings. Hospitals and outpatient surgical facilities use these products to cover incisions, manage drainage, protect tissues, and support postoperative recovery.

Surgical dressings are required across cardiovascular, orthopedic, neurological, gastrointestinal, oncology, and general surgical procedures. The expansion of ambulatory surgery centers and the availability of specialized treatments further contribute to product consumption.

Surgical-site infection prevention is another important consideration. According to the source material, the CDC’s 2024 Healthcare-Associated Infections Progress Report recorded a 4% reduction in surgical-site infections following colon surgery compared with 2023, while infections following abdominal hysterectomy increased by 8%.

These differences highlight the continuing need for effective infection-control practices and appropriate postoperative wound management.

Manufacturers are responding with products featuring antimicrobial materials, absorbent layers, protective barriers, and skin-friendly adhesives. Such innovations can help healthcare providers select dressings according to wound characteristics and clinical requirements.

2. Increasing Prevalence of Chronic Wounds and Diabetes

Chronic wounds represent a significant healthcare challenge in the United States. Diabetes, vascular disease, obesity, and other chronic conditions can interfere with normal healing and increase the likelihood of persistent wounds.

The source material reports that approximately 10.5 million U.S. Medicare beneficiaries had wounds in 2019, compared with 8.2 million in 2014. Wound prevalence increased from 14.5% to 16.4% over the same period.

Diabetes is an important contributor to wound-care demand because associated nerve damage and poor circulation can increase the risk of foot injuries, ulcers, and delayed healing.

Patients with chronic wounds may require repeated dressing changes, ongoing clinical monitoring, and products suited to their wound’s moisture and exudate characteristics. Consequently, healthcare providers need a broad selection of wound-care materials.

This growing clinical burden creates opportunities for manufacturers offering advanced absorbent dressings, antimicrobial solutions, and products designed to protect surrounding skin.

3. Aging Population and Adoption of Advanced Wound-Care Products

Population aging is expected to support long-term market expansion. Older adults are more likely to undergo surgical procedures and experience chronic conditions that complicate wound healing.

As the U.S. population ages, hospitals, nursing facilities, rehabilitation centers, and home healthcare providers will require products that address postoperative wounds, pressure injuries, and other skin-related complications.

Advanced dressings are attracting attention because they can offer benefits such as improved moisture management, greater absorbency, reduced skin trauma, and longer wear times, depending on the product and clinical application.

Healthcare providers are also looking for solutions that simplify dressing changes and improve patient comfort. Products that support efficient clinical workflows may become increasingly attractive when their benefits justify the additional acquisition cost.

4. Technological Innovation and Product Development

Innovation is transforming the competitive landscape of the U.S. surgical dressings market. Manufacturers are developing specialized products with improved materials, antimicrobial properties, transparent monitoring capabilities, and simplified application procedures.

Recent examples include negative-pressure wound therapy dressings, silver-based antimicrobial dressings, advanced foam dressings, and silk-based surgical dressings.

These innovations reflect several industry priorities:

• Improving wound protection and exudate management.
• Supporting appropriate moisture balance.
• Reducing unnecessary disturbance during wound inspection.
• Improving adhesion while protecting sensitive skin.
• Simplifying application and dressing replacement.
• Providing specialized options for different wound types.

However, the suitability of each product depends on its intended use, clinical evidence, and the patient’s condition. Advanced products are not universally interchangeable, making clinical assessment and appropriate product selection essential.

Challenges Facing the U.S. Surgical Dressings Market

High Product Costs and Reimbursement Pressure

The cost of advanced surgical dressings can limit their adoption, particularly in healthcare facilities operating under strict procurement budgets.

Conventional gauze and basic adhesive products are generally less expensive than specialized antimicrobial, bioactive, hydrocolloid, and advanced foam dressings. Hospitals and healthcare payers therefore evaluate whether premium products provide sufficient clinical and economic value.

The source material estimates U.S. wound-related expenditures among Medicare beneficiaries at US$22.5 billion in 2019 under the study’s most conservative costing method.

Manufacturers must demonstrate how their products may contribute to effective wound management, fewer dressing changes, improved patient comfort, or reduced complications. Pricing pressure and reimbursement requirements will remain important considerations during purchasing decisions.

Infection Risks and Complex Clinical Requirements

Surgical wounds can develop complications that require additional treatment and increase healthcare utilization. Dressing selection must account for factors such as wound location, fluid levels, skin sensitivity, infection risk, and the patient’s overall health.

Healthcare facilities also need products that meet appropriate requirements for sterility, adhesion, absorbency, moisture control, and skin compatibility.

Because different wounds require different approaches, no single dressing is suitable for every patient or clinical situation. This complexity creates challenges for standardized purchasing, staff training, and consistent product selection across healthcare settings.

Recent Surgical Dressing Product Launches and Innovations in the USA

Product development is an important competitive factor in the U.S. market. Examples identified in the source material include:

1. V.A.C. Peel and Place Dressing — Solventum, September 2024: An all-in-one dressing and drape designed for negative-pressure wound therapy, with an emphasis on simplifying application and dressing changes.
2. Microlyte Ag/Lidocaine — Imbed Biosciences, October 2024: Received FDA 510(k) clearance for an antimicrobial dressing combining silver-based technology with lidocaine for specified wound-management applications.
3. OptiView Transparent Dressing with HydroCore Technology — Medline, January 2024: Introduced a transparent dressing designed to support skin inspection without removing the dressing.
4. SYLKE Silk Surgical Dressing — Sylke Inc., October 2023: A silk fibroin-based dressing developed for surgical wound protection and skin compatibility.
5. ALLEVYN Ag+ Surgical Antimicrobial Dressing — Smith+Nephew, August 2023: Received FDA 510(k) clearance for a surgical dressing combining foam construction, silver-based antimicrobial technology, and silicone-gel adhesive.
6. ConvaFoam Advanced Foam Dressing — Convatec: A U.S. product family developed for wound protection and exudate management across a range of applications.
7. Atrauman Ag — HARTMANN USA, December 2024: Received FDA 510(k) clearance for a non-adherent silver-impregnated antimicrobial dressing intended for specified wound types.
8. Biatain Silicone Fit — Coloplast, 2024: Expanded the company’s U.S. portfolio of silicone foam dressings for wound management and pressure-injury prevention.
9. Cinesteam Wound Dressing — Cemag Care/Clara Care, April 2025: Introduced through a U.S. institutional partnership, combining an absorbent secondary dressing with a cinnamon-containing sachet intended to address wound odor.
10. Hemastyl Wound Treatment — Rapid Nexus, May 2026: The source material identifies commercial deployment following contracts with the Department of Veterans Affairs and Department of Defense.

These examples illustrate the industry’s emphasis on advanced materials, antimicrobial technologies, application convenience, and specialized wound-management needs. Product availability, indications, and regulatory status should be verified against current manufacturer and FDA information before clinical or commercial use.

Market Segmentation of the United States Surgical Dressings Market

The market can be analyzed across product, application, end-use, and geographic categories.

By Product

• Primary dressings
• Secondary dressings
• Other dressing products

Primary dressings are applied directly to wounds, while secondary dressings may provide additional protection, absorbency, or support.

By Application

• Diabetes-based surgeries
• Cardiovascular diseases
• Ulcers
• Burns
• Transplant sites
• Other applications

Demand varies according to procedure volumes, wound characteristics, chronic disease prevalence, and the need for postoperative care.

By End Use

• Hospitals
• Ambulatory surgery centers
• Specialty centers
• Home healthcare
• Other healthcare settings

Hospitals are a major end-user segment because they manage complex surgeries, emergency cases, and patients requiring intensive postoperative care. Ambulatory surgery centers and home healthcare providers also contribute to demand.

Regional Outlook: Key State Markets

California

California is an important market because of its large population, extensive healthcare infrastructure, major medical centers, and concentration of research institutions. Its hospital network and outpatient surgical services support demand for conventional and advanced dressings.

Texas

Texas offers growth opportunities associated with population expansion, healthcare infrastructure development, and demand for specialized medical services. Major healthcare centers in Houston, Dallas–Fort Worth, Austin, and San Antonio support product consumption.

Florida

Florida’s relatively large older population creates demand for surgical care and wound management. Hospitals, rehabilitation facilities, long-term care providers, and senior-care services represent important purchasing channels.

New York

New York benefits from a developed healthcare system and a concentration of major medical centers. Complex surgical procedures, specialized treatments, and outpatient healthcare services contribute to demand for advanced dressing products.

Other states covered in the market analysis include Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, and Kentucky, along with the rest of the United States.

Competitive Landscape and Key Companies

Competition in the U.S. surgical dressings market centers on product performance, clinical suitability, pricing, distribution, innovation, and relationships with healthcare providers.

Key companies covered in the market analysis include:

• Smith+Nephew plc
• Essity AB
• DeRoyal Industries, Inc.
• 3M
• Integra LifeSciences Holdings Corporation
• Cardinal Health, Inc.
• MiMedx Group, Inc.
• Medtronic plc

The competitive landscape includes companies with portfolios spanning traditional wound-care products, advanced dressings, specialized materials, and related medical technologies.

Manufacturers can strengthen their market positions by developing differentiated products, expanding distribution networks, supporting clinical education, and demonstrating the value of advanced wound-care solutions.

The Renub Research market analysis covers key companies through five viewpoints: company overviews, key personnel, recent developments, SWOT analysis, and revenue analysis.

Future Outlook for the United States Surgical Dressings Market

The U.S. surgical dressings market is expected to expand steadily through 2034 as surgical activity, chronic wound prevalence, population aging, and advanced wound-care adoption continue to shape demand.

The projected increase from US$1.47 billion in 2025 to US$2.09 billion by 2034 reflects opportunities for manufacturers serving hospitals, ambulatory surgical facilities, specialty centers, and home healthcare providers.

Future competition will likely emphasize product differentiation, patient comfort, effective moisture management, antimicrobial technologies, and cost-efficient treatment. Manufacturers that demonstrate clinical value while meeting healthcare providers’ budget and procurement requirements may be better positioned to capture growth.

For healthcare organizations and industry stakeholders, understanding product categories, clinical applications, regional opportunities, and competitive developments will be important for strategic planning.

Frequently Asked Questions (FAQs)

1. What is the size of the United States surgical dressings market?

The United States surgical dressings market is projected to reach US$1.47 billion in 2025 and US$2.09 billion by 2034, according to the supplied market estimates.

2. What is the CAGR of the U.S. surgical dressings market?

The market is expected to register a CAGR of 3.98% during the 2026–2034 forecast period.

3. What factors are driving market growth?

Key growth drivers include increasing surgical procedures, rising chronic wound prevalence, diabetes-related complications, population aging, and the adoption of advanced wound-care products.

4. What are the major types of surgical dressings?

Major types include gauze, adhesive dressings, foam dressings, hydrocolloids, alginates, hydrogels, transparent films, antimicrobial dressings, and bioactive dressings.

5. Which end-user segment is important in the U.S. surgical dressings market?

Hospitals represent a major end-user segment because of their extensive surgical activity, complex wound-management requirements, and need for postoperative care. Ambulatory surgery centers, specialty centers, and home healthcare providers also contribute to demand.

6. What challenges affect the surgical dressings market?

Important challenges include the high cost of advanced products, reimbursement pressure, procurement constraints, infection-control requirements, and the complexity of selecting appropriate dressings for different wound types.

7. Which companies are key participants in the U.S. surgical dressings market?

Key companies identified in the market analysis include Smith+Nephew, Essity, DeRoyal Industries, 3M, Integra LifeSciences, Cardinal Health, MiMedx Group, and Medtronic.

8. What are the major trends shaping the market?

Major trends include antimicrobial dressing development, advanced foam technologies, transparent wound monitoring, improved skin-compatible adhesives, specialized materials, and products designed to simplify dressing application and replacement.

9. Which states offer important market opportunities?

California, Texas, Florida, and New York are important state markets because of their large populations, healthcare infrastructure, and demand for surgical and wound-management services.

10. What is the forecast period for the United States surgical dressings market?

The forecast period is 2026–2034, with 2025 serving as the base-year market estimate in the supplied analysis.

About Renub Research

Renub Research is a market research and consulting company providing industry analysis, market sizing, competitive intelligence, and forecasts across healthcare and other industries. Its research supports businesses, investors, manufacturers, and decision-makers in evaluating market trends and identifying growth opportunities.